date:May 30, 2012
EFSAs Panel on Dietetic Products, Nutrition and Allergies (NDA) issued guidance this month on bone, joints, skin, and oral health claims.
Christiane Alexander, PhD, senior consultant at German consultancy analyze realize, said there was little guidance in the guidance about trial design that may win lead to approvals under the EUs new hyper-strict health claims system.
Impossible demands
Unfortunately, the guidance paper published last week by EFSA does not provide any useful clues for cli